SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028434
Filing Date
2023-08-14
Accepted
2023-08-14 16:06:29
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 848505
2 ex31-1.htm EX-31.1 12344
3 ex32-1.htm EX-32.1 4632
  Complete submission text file 0001493152-23-028434.txt   5762644

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE eltp-20230630.xsd EX-101.SCH 50701
5 XBRL CALCULATION FILE eltp-20230630_cal.xml EX-101.CAL 73956
6 XBRL DEFINITION FILE eltp-20230630_def.xml EX-101.DEF 190661
7 XBRL LABEL FILE eltp-20230630_lab.xml EX-101.LAB 376079
8 XBRL PRESENTATION FILE eltp-20230630_pre.xml EX-101.PRE 313350
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 863899
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 231169896
SIC: 2834 Pharmaceutical Preparations